|
Apr 17
|
Krystal Biotech to Report First Quarter 2025 Financial Results on May 6, 2025
|
|
Apr 8
|
Is Kiniksa Pharmaceuticals (KNSA) Outperforming Other Medical Stocks This Year?
|
|
Apr 7
|
Jeune Aesthetics Appoints Marc Forth as Chief Executive Officer
|
|
Apr 7
|
5 Biotech Stocks Worth Adding Amid Global Uncertainty in 2025
|
|
Feb 24
|
Why Krystal Biotech (KRYS) Might be Well Poised for a Surge
|
|
Feb 24
|
Why Krystal Biotech, Inc. (KRYS) is a Top Momentum Stock for the Long-Term
|
|
Feb 21
|
Krystal Biotech (KRYS) Upgraded to Buy: Here's What You Should Know
|
|
Feb 20
|
Krystal Biotech Q4 Earnings Beat Estimates, Sales Miss, Stock Up
|
|
Feb 20
|
3 US Growth Companies With High Insider Ownership Expecting Up To 68% Earnings Growth
|
|
Feb 20
|
Krystal Biotech Inc (KRYS) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic ...
|
|
Feb 20
|
Q4 2024 Krystal Biotech Inc Earnings Call
|
|
Feb 19
|
High Growth Tech Stocks in United States to Watch
|
|
Feb 19
|
Krystal Biotech Announces Fourth Quarter and Full Year 2024 Financial and Operating Results
|
|
Jan 24
|
Is the Options Market Predicting a Spike in Krystal Biotech (KRYS) Stock?
|
|
Jan 14
|
Jeune Aesthetics Appoints Nishant Saxena as Chief Financial Officer
|
|
Sep 27
|
ABBV's Newly Added Parkinson's Disease Drug Meets Second Study Goal
|
|
Sep 6
|
Krystal Biotech to Present at H.C. Wainwright 26th Annual Global Investment Conference
|
|
Sep 3
|
Surging Earnings Estimates Signal Upside for Krystal Biotech (KRYS) Stock
|
|
Aug 30
|
Krystal Biotech Stock Surges 21.9% in 3 Months: More Room to Grow?
|
|
Aug 28
|
Jeune Aesthetics Announces Phase 1 Positive Interim Safety and Efficacy Results for KB301 in the Treatment of Lateral Canthal Lines and Dynamic Wrinkles of the Décolleté
|